Amendments to the Patented Medicines Regulations

• October 24, 2007 The proposed amendments to the Patented Medicines Regulations, 1994, were published in the Canada Gazette, Part I, October 6, 2007 issue. Stakeholders had until October 22, 2007 to submit their comments on the proposed amendments to the Secretary of the Board. View comments received
• Proposed amendments to the Patented Medicines Regulations, 1994 - Update
• Proposed Amendments to the Patented Medicines Regulations, 1994 (PDF)
• Proposed Forms
  • Form 1: Medicine Identification Sheet (PDF)
  • Form 2: Information on the Identity and Prices of the Medicine (PDF)
  • List of Codes (PDF)
• Submissions
  • Patentees
    • Altana Pharma (PDF)
    • AstraZeneca Canada Inc. (PDF)
    • Boehringer Ingelheim (PDF)
    • Eli Lilly Canada Inc. (PDF)
    • GlaxoSmithKline Inc. (PDF)
    • Merck Frosst Canada & Co (PDF)
    • Novartis Pharmaceuticals Canada Inc. (PDF)
    • Novo Nordisk (PDF)
    • Pfizer Canada Inc. (PDF)
    • Purdue Pharma (PDF)
    • Sanofi Aventis (PDF)
    • Solvay Pharma (PDF)
    • Wyeth Canada Inc. (PDF)
• Provinces
  • Nunavut - Ministry of Health (PDF)
  • Ontario Ministry of Health and Long-Term Care, Drug Programs Branch (PDF)
  • Saskatchewan Health - Drug Plan & Extended Benefits (PDF)
• Associations
  • NDMAC (PDF)
  • Rx&D (PDF)
• Consultants
  • Brogan Inc. (PDF)
  • Peter Kaldas (PDF)
• Third Party Payers
  • Green Shield Canada (PDF)
• Proposed Amendments to the Patented Medicines Regulations, 1994 as published in the Canada Gazette, Part I of December 31, 2005 http://canadagazette.gc.ca/partI/2005/20051231/html/regle7-e.html